Top 5 Low Price Stocks To Invest In Right Now

Sometimes its helpful for investors in small cap mining stocks like Azincourt Energy Corp (TSX-V: AAZ; OTCMKTS: AZURF) to take a look at what other mining stocks operating in the same region and looking for the same minerals are doing or saying in order to have a better understanding of wherethe market is heading.

Denison Mines Corp’s Uranium Commentary

Last Thursday, small cap uranium mining stock Denison Mines Corp (NYSEAMERICAN: DNN), which is also focused on the Athabasca Basin of Saskatchewan, reported 2017 earnings and gave its outlook for 2018 with the outlook coming with extensive commentary about the uranium market and Athabasca. David Cates, the President and CEO of Denison Mines Corp, gave the following commentary:

“2017 was a volatile year for the uranium market. While the spot price of uranium benefited from upward momentum on multiple occasions during the year, that momentum was not sustained long enough for a meaningful change to the low price environment that saw the market reach 12 and 13 year lows in late 2016. Despite these disappointing market trends, Denison managed to have another productive year as we continue to focus on our strategy of positioning the Company for the future and a return to a much higher uranium price.”

Top 5 Low Price Stocks To Invest In Right Now: Templeton Dragon Fund Inc.(TDF)

Advisors’ Opinion:

  • [By Logan Wallace]

    News articles about Templeton Dragon Fund Inc common stock (NYSE:TDF) have trended somewhat positive on Sunday, Accern reports. The research firm identifies positive and negative media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Templeton Dragon Fund Inc common stock earned a media sentiment score of 0.11 on Accern’s scale. Accern also gave news headlines about the financial services provider an impact score of 45.9946586007156 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

  • [By Shane Hupp]

    Templeton Dragon Fund Inc common stock (NYSE:TDF) major shareholder City Of London Investment Grou bought 8,155 shares of the company’s stock in a transaction that occurred on Tuesday, June 12th. The shares were purchased at an average price of $22.87 per share, with a total value of $186,504.85. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Top 5 Low Price Stocks To Invest In Right Now: Axsome Therapeutics, Inc.(AXSM)

Advisors’ Opinion:

  • [By Paul Ausick]

    Axsome Therapeutics Inc. (NASDAQ: AXSM) traded down about 43% Tuesday and posted a new 52-week low of $3.20 after closing Monday at $5.55. The 52-week high is $6.45. Volume was about 3.8 million, about 19 times the daily average of around 220,000 shares. The company will stop a “futile” portion of a trial of its treatment for knee osteoarthritis.

  • [By Lisa Levin] Gainers
    Comstock Resources, Inc. (NYSE: CRK) shares shot up 52 percent to $7.235 after the company disclosed a deal with Arkoma Drilling L.P. and Williston Drilling, L.P. to buy oil & gas properties in North Dakota. Comstock announced withdrawal of tender offers for outstanding secured notes.
    MarineMax, Inc. (NYSE: HZO) shares gained 24.2 percent to $21.80 as the company posted upbeat Q2 results and raised its FY18 outlook.
    Mattersight Corporation (NASDAQ: MATR) shares rose 22 percent to $2.625 after the company agreed to be purchased by NICE Ltd.
    Chipotle Mexican Grill, Inc. (NYSE: CMG) jumped 21.3 percent to $411.871 as the company reported stronger-than-expected results for its first quarter on Wednesday.
    Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 17 percent to $3.10 after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression.
    Ultra Clean Holdings, Inc. (NASDAQ: UCTT) rose 15.9 percent to $18.34 following upbeat Q1 earnings.
    PCM, Inc. (NASDAQ: PCMI) gained 15.6 percent to $12.20 following Q1 results.
    O'Reilly Automotive, Inc. (NASDAQ: ORLY) surged 14.4 percent to $260.3901 following upbeat Q1 profit.
    Concord Medical Services Holdings Limited (NYSE: CCM) gained 13.8 percent to $3.70.
    Penn National Gaming, Inc. (NASDAQ: PENN) rose 13.5 percent to $29.815 after reporting strong Q1 results.
    BioTelemetry, Inc. (NASDAQ: BEAT) rose 13.5 percent to $38.30 as the company reported stronger-than-expected earnings for its first quarter.
    Advanced Micro Devices, Inc. (NASDAQ: AMD) shares rose 13.1 percent to $10.985 as the company reported upbeat results for its first quarter.
    SJW Group (NYSE: SJW) shares gained 11.8 percent to $63.59 following Q1 results. California Water Service Group made an offer for SJW.
    Churchill Downs Incorporated (NASDAQ: CHDN) climbed 9.8 percent to $278.40 following Q1 results.
    CYS Investments, Inc. (NYSE: CYS)
  • [By Chris Lange]

    Axsome Therapeutics Inc. (NASDAQ: AXSM) is evaluating AXS-05 in its Stride-1 Phase 3 trial in treatment-resistant depression. Top-line results are expected by the end of March. Axsome previously received an FDA Fast Track designation for AXS-05.

  • [By Max Byerly]

    Axsome Therapeutics (NASDAQ:AXSM) released its quarterly earnings results on Tuesday. The company reported ($0.19) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.28) by $0.09, Bloomberg Earnings reports.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Axsome Therapeutics (AXSM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Low Price Stocks To Invest In Right Now: Cumberland Pharmaceuticals Inc.(CPIX)

Advisors’ Opinion:

  • [By Logan Wallace]

    JW Asset Management LLC cut its stake in Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) by 32.2% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 178,942 shares of the specialty pharmaceutical company’s stock after selling 84,939 shares during the period. Cumberland Pharmaceuticals comprises about 1.2% of JW Asset Management LLC’s holdings, making the stock its 16th largest holding. JW Asset Management LLC owned about 1.14% of Cumberland Pharmaceuticals worth $1,195,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Max Byerly]

    COPYRIGHT VIOLATION NOTICE: “Cumberland Pharmaceuticals (CPIX) Research Coverage Started at B. Riley” was originally posted by Ticker Report and is the property of of Ticker Report. If you are reading this report on another domain, it was copied illegally and republished in violation of US and international copyright & trademark legislation. The legal version of this report can be accessed at www.tickerreport.com/banking-finance/3364464/cumberland-pharmaceuticals-cpix-research-coverage-started-at-b-riley.html.

Top 5 Low Price Stocks To Invest In Right Now: Coca-Cola Enterprises, Inc.(CCE)

Advisors’ Opinion:

  • [By Logan Wallace]

    Clinton Group Inc. acquired a new position in shares of Coca-Cola European Partners PLC (NYSE:CCE) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 128,976 shares of the company’s stock, valued at approximately $5,242,000. Coca-Cola European Partners comprises 0.8% of Clinton Group Inc.’s investment portfolio, making the stock its 20th largest holding.

  • [By Shane Hupp]

    Coca-Cola European Partners (NYSE:CCE) announced its quarterly earnings results on Thursday. The company reported $0.67 earnings per share for the quarter, missing analysts’ consensus estimates of $0.78 by ($0.11), Bloomberg Earnings reports. Coca-Cola European Partners had a return on equity of 15.52% and a net margin of 5.70%. The company had revenue of $3.06 billion during the quarter, compared to analyst estimates of $3.07 billion. During the same period in the prior year, the firm earned $0.67 EPS. Coca-Cola European Partners’s quarterly revenue was up .1% on a year-over-year basis. Coca-Cola European Partners updated its FY18 guidance to EUR2.25-2.27 EPS.

  • [By Stephan Byrd]

    These are some of the headlines that may have effected Accern Sentiment Analysis’s analysis:

    Get Coca-Cola European Partners alerts:

    Coca-Cola European Partners (CCE) Lowered to “Sell” at ValuEngine (americanbankingnews.com) $3.69 Billion in Sales Expected for Coca-Cola European Partners (CCE) This Quarter (americanbankingnews.com) Zacks: Analysts Anticipate Coca-Cola European Partners (CCE) to Post $0.81 EPS (americanbankingnews.com) Critical Contrast: Coca-Cola European Partners (CCE) and Coca-Cola Bottling Co. Consolidated (COKE) (americanbankingnews.com) Coca-Cola European Partners (CCE) Sees Large Drop in Short Interest (americanbankingnews.com)

    Shares of CCE traded down $0.51 during trading hours on Monday, hitting $37.88. The stock had a trading volume of 705,278 shares, compared to its average volume of 1,496,087. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.03 and a quick ratio of 0.79. The company has a market cap of $18.60 billion, a PE ratio of 15.85, a P/E/G ratio of 1.93 and a beta of 0.76. Coca-Cola European Partners has a 1-year low of $36.17 and a 1-year high of $44.75.

  • [By ]

    Analysts upgraded Coca-Cola European Partners PLC  (CCE) to buy on its commitment to deleveraging and capital allocation.

    Goldman still rates Monster Beverage Corp. (MNST) as a buy given the global expansion of the energy drink category.

  • [By Joseph Griffin]

    Commonwealth of Pennsylvania Public School Empls Retrmt SYS purchased a new stake in shares of Coca-Cola European Partners PLC (NYSE:CCE) during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 31,000 shares of the company’s stock, valued at approximately $1,260,000.

Top 5 Low Price Stocks To Invest In Right Now: Biotricity (BTCY)

Advisors’ Opinion:

  • [By Peter Graham]

    For small cap investors, Biotricity Inc (OTCQB: BTCY) is a good example of an up-and-coming Internet of Medical Things stock that is looking to cash in on the coming transformation of health care. The Company is building a remote patient monitoring platform comprised of three key components tailored to a variety of diagnostic and post-diagnostic applications:

  • [By Peter Graham]

    Small cap Internet of Medical Things (IoMT) company Biotricity, Inc (OTCBB: BTCY) has just announced that it will be expanding the scope of a previously approved clinical investigation of fetal heart rate variability (fHRV) to include maternal HRV and other key physiologic metrics for maximum predictive accuracy and efficiency. This is potentially a good area to be in due to the fact that high-risk pregnancies require extensive monitoring and care during the gestational period. High-risk pregnancies are also on the rise and now account for 6 – 8% of all pregnancies in the U.S. due in part to a rise in existing maternal health conditions (such as high blood pressure and obesity) and older parental age at the time of pregnancy. This means that the maternal and fetal monitoring market is growing rapidly and is expected to be worth $2.3 Billion by 2019. 

  • [By Peter Graham]

    According to a recent report (“Internet of Medical Things Enabling Hospitals of the Future”) from Frost & Sullivan, the Internet of Medical Things (IoMT) is helping to drive the home healthcare industry into new innovations that are clustered around wearables and eSkin devices – the type of devices that small cap Biotricity Inc (OTCQB: BTCY) is developing. To begin with, the Internet of Medical Things is part of the much bigger Internet of Things (IoT) idea with IoMT consisting connected medical devices or applications feeding medical or patient data into the cloud via online networks. In addition and aside from Internet of Medical Things, there is also another trend in healthcare to move away from “reactive” healthcare where a patient visits a healthcare facility to deal with a problem and to instead move toward “proactive” healthcare care where the patient takes a degree of responsibility for their own health through the use of health monitoring systems (enabled by IoMT). 

Leave a Reply

Your email address will not be published. Required fields are marked *